This website uses cookies to enhance the user experience.
N

NUSEVA AS917 955 298

Research
Limited company
c/o Claudia A. Bøen Bjørnenga 40 1364 FORNEBU, Norge

NUSEVA AS

Nuseva – Nuseva AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
9 years
since Oct 28, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
30,000
1 share class
Total number of shareholders
2
persons

Financials

Total operating income 2024
70,077
NOK
Annual total result 2024
61,472
NOK
Total equity 2024
-185,092
NOK
Last update: May 27, 2025

Management

Board

NameRoleShares
Chairman
50 %
directly
Board Member
50 %
directly

Top 10 individual shareholders

NameRoleShares
Board Member
50 %
directly
Chairman
50 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
15,000
50 %
Ordinary shares
15,000
50 %

Shares owned by the NUSEVA AS

NameShare classTotal number of sharesShare
P
PERSON-AIZ AS
Ordinary shares
65,875
13.78 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
70,077
456,816
104,454
50,000
Annual Total Result
61,472
-50,084
-156,469
-269,876
Total assets
636,363
743,671
663,023
428,591
Total liabilities
821,456
990,236
859,503
468,604
Total equity
-185,092
-246,565
-196,481
-40,013

P&L

Year2024202320222021
Total operating income
70,077
456,816
104,454
50,000
Total operating costs
8,311
479,799
260,972
306,344
Operating result
61,766
-22,983
-156,518
-256,344
Financial income/costs
-294
-49
49
0
Profit before tax
61,472
-23,032
-156,469
-256,344
Total tax & extraordinary income/cost
0
27,052
0
13,532
Annual Total Result
61,472
-50,084
-156,469
-269,876

Balance overview

Year2024202320222021
Total fixed assets
248,953
258,708
318,509
164,903
Total current assets
387,410
484,963
344,514
263,688
Total assets
636,363
743,671
663,023
428,591
Short term debt
48,956
217,736
87,003
80,604
Long term debt
772,500
772,500
772,500
388,000
Total liabilities
821,456
990,236
859,503
468,604
Contributed capital
30,000
30,000
30,000
30,000
Retained earnings
-215,092
-276,565
-226,481
-70,013
Total equity
-185,092
-246,565
-196,481
-40,013
Total equity and liabilities
636,364
743,671
663,022
428,591

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology